Replies to post #15489 on Hard to Treat Diseases (HTDS)

[FiduciaryDuty911]

HTDS is such a real company with such a bright future.

[FiduciaryDuty911]

I think clearly HTDS is a good stock that's going to be big!

[FiduciaryDuty911]

I think HTDS.PK the stock is NOT garbage. I repeat HTDS.pK is NOT garbage. ROFLLAWL!!!!!

[mobily]

if they r/s 4000 to 1

[Navy-1]

The HTDS PR for Nov 19th clearly states that the 200,000 doses of H1N1 vaccine is worth 1.8m USD($9/dose), with an additional 4-6m in the offering. Hmmm, 1.8m USD + (4-6m doses @ $7/dose= 28-42m USD, sounds like quite a deal for HTDS being the delivery boy.

[penny4yuu]

It is about 10% markup. This Company is trading at 100 times Profit. amazing is it not?lol

HTDS — Hard to Treat Diseases, Inc.
Class Common Stock
Par Value: 0.01


QuoteNewsChartsCompany InfoFilingsResearchShort InterestInsider Trans.Pink OTC Markets has discontinued the display of quotes on pinksheets.com for this security because it has been labeled Caveat Emptor (Buyer Beware) and because adequate current information has not been made available by the issuer of the securities. It has been labeled Caveat Emptor for one of the following reasons:
•Questionable Promotion — The security is being promoted to the public, but adequate current information about the issuer has not been made available to the public.
•Spam — The security is the subject of spam promotion having the effect of encouraging trading of the issuer's securities.
•Investigation of Fraud — There is a known investigation of fraudulent activity involving the company, its securities or insiders.
•Suspension/Halt — A Regulatory Authority has halted or suspended trading for public interest concerns (i.e. not a news or earning halt).
•Disruptive Corporate Actions — The security or issuer is the subject of corporate actions, such as reverse mergers or serial stocks splits and name changes, without adequate current information being publicly available.
•Unsolicited Quotes — The security has only been quoted on an unsolicited basis since it entered the public markets and the issuer has not made adequate current information available to the public.
•Other Public Interest Concern — There is, in Pink OTC Markets' view, a public interest concern.
Consequently, Pink OTC Markets has removed the quotes from this website until adequate current information is made available by the issuer pursuant to Pink OTC Markets Guidelines for Providing Adequate Current Information (PDF) and until Pink OTC Markets believes there is no longer a public interest concern. Investors are encouraged to use care and due diligence in their investment decisions. Please read our Investor Protection page for more information.